PharmaShots | Incisive News in 3 Shots

Subscribe Now

IDEAYA

IDEAYA Amends Clinical Trial Collaboration and Supply Agreements with Pfizer to Evaluate Darovasertib + Crizotinib Combination in 1L Metastatic Uveal Melanoma

IDEAYA Amends Clinical Trial Collaboration and Supply Agreements with Pfizer to Evaluate Darovasertib + Crizotinib Combination in...

May 16, 2023

IDEAYA Receives Milestones in its Pol Theta Helicase Inhibitor with GSK for Patients Harboring Tumors with BRCA

IDEAYA Receives Milestones in its Pol Theta Helicase Inhibitor with GSK for Patients Harboring Tumors with BRCA

August 29, 2022

IDEAYA Entered into a Clinical Trial Collaboration and Supply Agreement with Amgen for IDE397 + AMG 193 in MTAP Deleted Solid Tumors

IDEAYA Entered into a Clinical Trial Collaboration and Supply Agreement with Amgen for IDE397 + AMG 193 in MTAP Deleted Solid Tumo...

July 27, 2022

Ideaya Expands its 2020 Collaboration and Supply Agreements with Pfizer for Darovasertib + Crizotinib to Treat Metastatic Uveal Melanoma and cMET-Driven Tumors

Ideaya Expands its 2020 Collaboration and Supply Agreements with Pfizer for Darovasertib + Crizotinib to Treat Metastatic Uveal Me...

March 14, 2022

IDEAYA and Pfizer Expand CTC and Supply Agreement for Solid Tumors Harboring GNAQ or GNA11 Mutations

IDEAYA and Pfizer Expand CTC and Supply Agreement for Solid Tumors Harboring GNAQ or GNA11 Mutations

September 24, 2020

PharmaShots Weekly Snapshot (March 16-20, 2020)

PharmaShots Weekly Snapshot (March 16-20, 2020)

March 23, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us